Johnson & Johnson

About

Allen Wang is currently a Principal Scientist/Global Technical Lead at Ethicon Biosurgery of Johnson & Johnson Medical Devices Companies and serves as a mentor at JLABS of Johnson & Johnson Innovation to connect and provide support to early-stage companies in the innovative external ecosystem. In 2008, after obtaining his PhD from Johns Hopkins University, Allen joined Johnson & Johnson Wound Management R&D and quickly set the standard of excellence, holding over 70 patents and 45 patent applications worldwide and several peer‐reviewed publications, and developing several new surgical products to help more patients. His most recent Class III medical device invention, SURGICEL Powder Absorbable Hemostat, has served numerous patients in more than 40 countries since its launch in late 2017 and led to Allen and his team being awarded the 2021 Edison Patent Award, 2020 Johnson Medal and several prestigious international awards such as the 2018 Gold Medical Design Excellence Award in the Drug‐Delivery Devices and Combination Products and the 2018 R&D 100 Award. Besides he was awarded the 2021 Johns Hopkins Distinguished Alumnus Award. Currently, he continues to work with J&J divisions globally to expand the Biosurgery product portfolio and generate novel surgical products for their future pipeline to address unmet surgical needs to enhance the health of people all over the world.